Immune capture and protein profiling of small extracellular vesicles from human plasma

Author:

Skoczylas Łukasz1,Gawin Marta1ORCID,Fochtman Daniel12,Widłak Piotr3,Whiteside Theresa L.456,Pietrowska Monika1ORCID

Affiliation:

1. Maria Sklodowska‐Curie National Research Institute of Oncology Gliwice Poland

2. Silesian University of Technology Gliwice Poland

3. Medical University of Gdańsk Gdańsk Poland

4. UPMC Hillman Cancer Center University of Pittsburgh Cancer Institute Pittsburgh PA USA

5. Department of Pathology University of Pittsburgh School of Medicine Pittsburgh PA USA

6. Department of Immunology University of Pittsburgh School of Medicine Pittsburgh PA USA

Abstract

AbstractExtracellular vesicles (EVs), the key players in inter‐cellular communication, are produced by all cell types and are present in all body fluids. Analysis of the proteome content is an important approach in structural and functional studies of these vesicles. EVs circulating in human plasma are heterogeneous in size, cellular origin, and functions. This heterogeneity and the potential presence of contamination with plasma components such as lipoprotein particles and soluble plasma proteins represent a challenge in profiling the proteome of EV subsets by mass spectrometry. An immunocapture strategy prior to mass spectrometry may be used to isolate a homogeneous subpopulation of small EVs (sEV) with a specific endocytic origin from plasma or other biofluids. Immunocapture selectively separates EV subpopulations in biofluids based on the presence of a unique protein carried on the vesicle surface. The advantages and disadvantages of EV immune capture as a preparative step for mass spectrometry are discussed.

Funder

Narodowe Centrum Nauki

National Institutes of Health

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Reference87 articles.

1. Exosomes in cancer: Another mechanism of tumor‐induced immune suppression;Whiteside T. L.;Advances in Experimental Medicine and Biology,2017

2. Exosomes in inflammation and role as biomarkers;Console L.;Clinica Chimica Acta; International Journal of Clinical Chemistry,2019

3. Current progresses of exosomes as cancer diagnostic and prognostic biomarkers;Huang T.;International Journal of Biological Sciences,2019

4. Exosomes as a liquid biopsy for lung cancer;Cui S.;Lung Cancer (Amsterdam, Netherlands),2018

5. Exosomes as a multicomponent biomarker platform in cancer;Lebleu V S.;Trends in Cancer,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3